These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2007290)

  • 81. Detection of alpha1 integrin in urine of patients with immunoglobulin A nephropathy.
    Bank J; Ben-David A; Doolman R; Sela BA; Bank I
    J Investig Med; 2008 Mar; 56(3):581-6. PubMed ID: 18418126
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Urine afamin and afamin-creatinine ratio as biomarkers for kidney injury.
    Pang L; Duan N; Xu D; Jiao L; Huang C; Du J; Guo Q; Li H
    Biomark Med; 2018 Nov; 12(11):1241-1249. PubMed ID: 30433819
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Prognostic assessment of IgA nephropathy: how much does histology add?
    Floege J
    Kidney Int; 2016 Jan; 89(1):19-21. PubMed ID: 26759041
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Beta 2-microglobulin in IgA nephropathy].
    Hou FF; Zhang X
    Zhonghua Nei Ke Za Zhi; 1987 Oct; 26(10):580-3, 621-2. PubMed ID: 3325245
    [No Abstract]   [Full Text] [Related]  

  • 85. Utility of skin biopsy in the diagnosis of IgA nephropathy.
    Hené RJ; Velthuis P; van de Wiel A; Kater L; Mees EJ
    Am J Kidney Dis; 1986 May; 7(5):442. PubMed ID: 3706299
    [No Abstract]   [Full Text] [Related]  

  • 86. Effect of smoking on urinary NOx and cGMP excretion in IgA nephropathy and in health.
    Kovács T; Vas T; Wagner L; Schmelczer M; Kocsis B; Nagy J
    Contrib Nephrol; 2000; 130():124-9. PubMed ID: 10892558
    [No Abstract]   [Full Text] [Related]  

  • 87. IgA nephropathy, consanguinity and hypertension.
    Nomura S; Fukushima T; Kawai S; Osawa G
    Nephron; 1996; 73(1):101. PubMed ID: 8742968
    [No Abstract]   [Full Text] [Related]  

  • 88. Images in clinical medicine. Dysmorphic urinary erythrocytes.
    Saad TF
    N Engl J Med; 1996 May; 334(22):1440. PubMed ID: 8618583
    [No Abstract]   [Full Text] [Related]  

  • 89. IgA nephropathy in HIV infection.
    Méry JP; Kenouch S
    Am J Nephrol; 1991; 11(5):439. PubMed ID: 1809045
    [No Abstract]   [Full Text] [Related]  

  • 90. IgA Nephropathy: "The Times They Are a-Changin".
    Glassock RJ
    Glomerular Dis; 2022 Jan; 2(1):4-14. PubMed ID: 36751269
    [TBL] [Abstract][Full Text] [Related]  

  • 91. First National Symposium on IgA Nephropathy. Washington, DC, March 17-18, 1988. Proceedings.
    Am J Kidney Dis; 1988 Nov; 12(5):337-453. PubMed ID: 3189322
    [No Abstract]   [Full Text] [Related]  

  • 92. Corrigendum to "MiR-100-3p and miR-877-3p regulate overproduction of IL-8 and IL-1β in mesangial cells activated by secretory IgA from IgA nephropathy patients" [Exp. Cell Res. 347 (2016) 312-321].
    Liang Y; Zhao G; Tang L; Li T; Zhang J; Liu Z
    Exp Cell Res; 2016 Nov; 349(1):198. PubMed ID: 27745865
    [No Abstract]   [Full Text] [Related]  

  • 93. Targeted-release budesonide therapy for IgA nephropathy.
    Tsuda K; Tanimoto T; Mori J; Kosugi K; Komatsu T
    Lancet; 2017 Dec; 390(10113):2625. PubMed ID: 29256403
    [No Abstract]   [Full Text] [Related]  

  • 94. Abstracts of the 27th Study Group IgA Nephropathy. Tokyo, Japan. January 24, 2004.
    Nephrology (Carlton); 2004 Dec; 9 Suppl 2():A47-65. PubMed ID: 15634240
    [No Abstract]   [Full Text] [Related]  

  • 95. Abstracts of the 28th Study Group on IgA Nephropathy, Tokyo, Japan, 29 January 2005.
    Nephrology (Carlton); 2005 Dec; 10 Suppl 6():A429-44. PubMed ID: 16354280
    [No Abstract]   [Full Text] [Related]  

  • 96. Abstracts of the 29th Study Group on IgA Nephropathy. January 28, 2006. Tokyo, Japan.
    Nephrology (Carlton); 2006 Oct; 11 Suppl 3():A57-70. PubMed ID: 17010085
    [No Abstract]   [Full Text] [Related]  

  • 97. An Overview of IgA Nephropathy: 50 Years On.
    Tang SCW
    Semin Nephrol; 2018 Sep; 38(5):433-434. PubMed ID: 30177014
    [No Abstract]   [Full Text] [Related]  

  • 98. Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports.
    Tota M; Baron V; Musial K; Derrough B; Konieczny A; Krajewska M; Turkmen K; Kusztal M
    J Clin Med; 2023 Apr; 12(7):. PubMed ID: 37048809
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Targeted-release budesonide therapy for IgA nephropathy - Authors' reply.
    Fellström B; Barratt J; Flöge J; Jardine A
    Lancet; 2017 Dec; 390(10113):2625-2626. PubMed ID: 29256402
    [No Abstract]   [Full Text] [Related]  

  • 100. Clinical features and course of IgA glomerulonephritis.
    Nagy J; Brasch H; Trinn C; Burger T
    Acta Med Acad Sci Hung; 1982; 39(3-4):201-10. PubMed ID: 7185246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.